84
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial

, , , , , , , , , , , & show all
Pages 1-9 | Published online: 19 Dec 2014

References

  • Peterson L, Nanda K, Opoku BK, et al. SAVVY®(C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PloS One. 2007;2(12):e1312.
  • Feldblum PJ, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PloS One. 2008;3(1):e1474.
  • Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PloS One. 2008;3(11):e3784.
  • Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–1987.
  • Gappoo S, Montgomery ET, Gerdts C, et al. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials. 2009;30(5):411–418.
  • Ramjee G, Coumi N, Dladla-Qwabe N, et al. Research experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa. AIDS Res Ther. 2010;7:10.
  • Naidoo K. Screening for the VOICE Study at eThekwini site: lessons learnt and implications for retention in future studies. Presented at: the VOICE MTN Regional Meeting; Cape Town, South Africa; 2012.
  • Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–261.
  • Djomand G, Metch B, Zorrilla CD, et al. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr. 2008;48(1):82–89.
  • Karim QA, Kharsany AB, Frohlich JA, et al. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. Trials. 2011;12(67):35.
  • Seyama L. Community engagement in HPTN 035. Presented at: the Microbicide Trials Network Annual Meeting; Arlington, Virginia; 2009.
  • Koblin BA, Metch B, Novak RM, et al. Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906. J Acquir Immune Defic Syndr. 2013;63(2):239–244.
  • Corneli A, Mack N, Kirkendale S; Truvada SBC Investigator and FHI Group. Socio-behavioral and community activities for an oral HIV prevention PrEP clinical trial: a multi-disciplinary approach. Presented at: the Microbicide Trials Network Annual Meeting; Delhi, India; 2008.
  • Weir SS, Morroni C, Coetzee N, Spencer J, Boerma JT. A pilot study of a rapid assessment method to identify places for AIDS prevention in Cape Town, South Africa STI. 2002;78(Suppl 1):i106–i113.
  • Weir SS, Pailman C, Mahlalela X, Coetzee N, Meidany F, Boerma JT. From people to places: focusing AIDS prevention efforts where it matters most. AIDS. 2003;17(6):895–903.
  • Weir SS, Tate JE, Zhusupov B, Boerma JT. Where the action is: monitoring local trends in sexual behaviour. STI. 2004;80 Suppl 2:ii63–ii68.
  • Wohl DA, Khan MR, Tisdale C, et al. Locating the places people meet new sexual partners in a southern US city to inform HIV/STI prevention and testing efforts. AIDS Behav. 2011;15(2):283–291.
  • Yamanis TJ, Maman S, Mbwambo JK, Earp JAE, Kajula LJ. Social venues that protect against and promote HIV risk for young men in Dar es Salaam, Tanzania. Soc Sci Med. 2010;71(9):1601–1609.
  • Brodish P, Singh K, Rinyuri A, et al. Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study. Drug Alcohol Depend. 2011;119(1):138–141.
  • Tate J, Singh K, Ndubani P, Kamwanga J, Buckner B. Measurement of HIV prevention indicators: a comparison of the PLACE method and a household survey in Zambia. AIDS Behav. 2010;14(1):209–217.
  • Speizer IS, Beauvais H, Gómez AM, Outlaw TF, Roussel B. Using multiple sampling approaches to measure sexual risk-taking among young people in Haiti: programmatic implications. Stud Fam Plann. 2009;40(4):277–288.
  • ESRI 2012. ArcGIS. Redlands, CA: Environmental Systems Research Institute.
  • Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1997;18(4):328–352.
  • Ogunsola F, Halpern V, Obunge O, et al. Recruitment strategies in the Phase III randomized controlled trial of cellulose sulfate gel and HIV in Nigeria. Presented at: the International AIDS Conference; Mexico City, Mexico; 2008.
  • Gutiérrez-Luna A, Angeles-Llerenas A, Wirtz VJ, et al. Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico. Clin Trials. 2009;(4):365–372.
  • Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. NEJM. 2012;367(5):411–422.
  • Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. NEJM. 2012;367(5):399–410.
  • OpenStreetMap.org [homepage on the Internet]. OpenStreetMap. Available from: http://www.openstreetmap.org/#map=5/51.509/7.603. Accessed October 29, 2014.
  • DIVA-GIS.org[homepage on the Internet]. DIVA-GIS. Available from: http://www.diva-gis.org/. Accessed October 29, 2014.